Revised: June/2026 Instructions for Use 0.25 mg, 0.5 mg, 1 mg single-dose prefilled syringe PRINCIPAL DISPLAY PANEL 0.25 mg or 0.5 mg doses, 2 mg/3mL Pen 0.25 mg 0.5 mg NDC 0169-4181-13List 418113 OZEMPIC (semaglutide) injection For Single Patient Use Only 2 mg/3 mL (0.68 mg/mL) Prefilled pen Pen delivers doses in 0.25 mg or 0.5 mg increments only For subcutaneous use only Use OZEMPIC once weekly Contains: 1 OZEMPIC pen, 6 NovoFine Plus 32G needles, Product Literature
What can the patient afford and access
Patients should review any new medications, skincare products, or dietary changes that coincide with symptom onset
Injecting semaglutide into muscle tissue (intramuscular injection) may result in faster absorption than intended, potentially causing increased injection site discomfort and altering the medication's pharmacokinetic profile
In fact, Ozempic was originally approved as a treatment for type 2 diabetes and has been shown to lower hemoglobin A1C levels